Jonathan L Catrow

Title: Innovations of Jonathan L Catrow

Introduction

Jonathan L Catrow is an accomplished inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific protein interactions. His work is vital for advancing treatments for various tumors and cancers.

Latest Patents

Jonathan L Catrow holds a patent for "Methods and compositions of substituted 5H-[1,2,5] oxadiazolo [3',4':5,6] pyrazino[2,3-B] indole analogs as inhibitors of β-catenin/T-cell factor protein-protein interactions." This invention relates to substituted 5H-[1,2,5]oxadiazolo [3',4':5,6]pyrazino[2,3-b]indole analogs, derivatives thereof, and related compounds. It includes synthetic methods for making these compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders associated with β-catenin/T-cell factor interaction dysfunction. This patent is crucial for developing new therapeutic strategies.

Career Highlights

Jonathan L Catrow is affiliated with the University of Utah Research Foundation, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential impact on cancer treatment and other related disorders.

Collaborations

He has collaborated with notable colleagues, including Haitao Ji and Yongqiang Zhang, to further enhance the research and development of his patented technologies.

Conclusion

Jonathan L Catrow's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his commitment to advancing medical treatments. His work continues to inspire future research in the area of cancer therapeutics.